Report #2829500

Overview

Sex

Male

Age

Age unknown

State

UT

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

The patient took first and second dose of Vivotif and went out of town for four days and wanted to know if the vaccination can be resumed; Case reference number US-BN-2024-001748 is a spontaneous case report initially received from a nurse via Med Communication (reference number: USBAV24-0625) on 02-Apr-2024 and concerns a male patient of unspecified age. The patient's medical history and concomitant medication was not provided. On unspecified date, reported as last week, the patient took first and second doses of Vivotif (batch number: unknown), orally, at an unknown dose, for typhoid prophylaxis. As reported, the patient went out of town for four days and the patient wanted to know if the vaccination should be resumed (explicitly coded as 'inappropriate schedule of vaccine administered'). At the time of the initial report, it was unknown if the patient experienced any adverse event due to Vivotif vaccine. No further information was provided.; Reporter's Comments: A male patient of unspecified age took first and second doses of Vivotif for typhoid prophylaxis. As reported, the patient went out of town for four days and the patient wanted to know if the vaccination should be resumed, which is considered as inappropriate schedule of vaccine administered. No associated adverse events were reported. Inappropriate schedule of vaccine administered is listed per company convention. The patient's medical history and concomitant medication was not provided. Inappropriate schedule of vaccine administered is not related to Vivotif, but to a human factor. The case is non-serious.; Sender's Comments: A male patient of unspecified age took first and second doses of Vivotif for typhoid prophylaxis. As reported, the patient went out of town for four days and the patient wanted to know if the vaccination should be resumed, which is considered as inappropriate schedule of vaccine administered. No associated adverse events were reported. Inappropriate schedule of vaccine administered is listed per company convention. The patient's medical history and concomitant medication was not provided. Inappropriate schedule of vaccine administered is not related to Vivotif, but to a human factor. The case is non-serious.

Medical history

Comments: None